CooperCompanies Announces Release Date for First Quarter 2022

Rhea-AI Summary

CooperCompanies (NYSE: COO) will release its Q1 2022 financial results on March 3, 2022, at 4:15 PM ET. Following the release, a conference call will be held at 5:00 PM ET to discuss results and corporate developments. Participants can join via dial-in or through the Company's website. A recording will be available after the call until March 10, 2022. CooperCompanies focuses on medical devices, operating through two units: CooperVision and CooperSurgical, and employs over 12,000 individuals globally.

Positive

• Scheduled Q1 2022 financial results indicate ongoing corporate activity.
• Conference call provides transparency regarding company results and developments.

Negative

• None.

SAN RAMON, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release first quarter 2022 financial results on Thursday, March 3, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months.  

A recording of the call will be available beginning at 8:00 PM ET on March 3, 2022 through March 10, 2022. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 266737.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com 

FAQ

When will CooperCompanies release its Q1 2022 financial results?

CooperCompanies will release its Q1 2022 financial results on March 3, 2022, at 4:15 PM ET.

What time is the conference call for CooperCompanies' Q1 2022 results?

The conference call will take place at 5:00 PM ET on March 3, 2022.

How can I access the CooperCompanies Q1 2022 conference call?

You can access the conference call by dial-in or through the Investor Relations section of CooperCompanies' website.

Will there be a recording available for CooperCompanies' conference call?

Yes, a recording will be available from 8:00 PM ET on March 3, 2022, until March 10, 2022.